SCHEMBL7326980

SCHEMBL7326980

CC(=O)Nc1cccc2c1CCC(=O)C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
ALDH1A1 P00352 5/20 0.48
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
KMT2A Q03164 1/20 0.47
HPGD P15428 2/20 0.42
MAOA P21397 2/20 0.42
CYP2A6 P11509 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADRA2A P08913 1/20 0.41
MAPK1 P28482 1/20 0.41
SLC18A3 Q16572 1/20 0.40
TYR P14679 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CASP3 P42574 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669256 0.88 NPC1 (0.57) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL1638724 0.79 ALDH1A1 (0.72) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL1613763 0.79 ALDH1A1 (0.68) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL30567324 0.79 ALDH1A1 (0.68) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL4877265 0.78 ALDH1A1 (0.70) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL7333057 0.76 CYP2A6 (0.46) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL4814588 0.74 NPC1 (0.56) NPC1RAB9AALDH1A1HPGDMAOA
SCHEMBL1011302 0.74 NPC1 (0.52) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL2251502 0.74 NPC1 (0.56) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL8851213 0.74 NPC1 (0.52) NPC1RAB9AALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed